FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals
Read MoreThe nationwide shortage of stimulant medications approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) remains unresolved nearly 1 year after
Read MoreDecember 15, 2023 1 min read Add topic to email alerts Receive an email when new articles are posted on
Read MorePharma money is all over the place — in universities, companies doing continuing medical education for doctors and in prominent
Read MoreThousands of readers reacted to the articles in the “Dying Broke” series about the financial burden of long-term care in
Read MoreDecember 14, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreThe Senate Finance Committee is ramping up oversight of Social Security’s overpayment problem and plans to meet with the agency
Read MoreSundar Pichai, CEO of Google and Alphabet, speaks on artificial intelligence during a Bruegel think tank conference in Brussels, Belgium,
Read MoreDecember 14, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on
Read MoreKetogenic diets are put to the test for diabetes reversal. As you can see at the start of my video Does
Read More